SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
26-Apr-24 4:56 PM View: | Inari Medical, Inc. (NARI) | 24-Apr-24 | Grant | 4,126 | $42.41 | $174,984.00 | < 1% 537.36K to 541.48K | |
30-May-23 4:37 PM View: | Inari Medical, Inc. (NARI) | 27-May-23 | Option Exercise | 2,982 | -- | -- | < 1% 534.38K to 537.36K | |
19-May-23 6:05 PM View: | Inari Medical, Inc. (NARI) | 18-May-23 | Grant | 2,412 | -- | -- | < 1% 531.96K to 534.38K | |
27-May-22 4:26 PM View: | Inari Medical, Inc. (NARI) | 27-May-22 | Option Exercise | 2,983 | -- | -- | < 1% 528.98K to 531.96K | |
27-May-22 4:26 PM View: | Inari Medical, Inc. (NARI) | 26-May-22 | Grant | 2,420 | -- | -- | < 1% 526.56K to 528.98K | |
28-Feb-22 8:04 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 25-Feb-22 | Disposition (other) | 3,473,540 | -- | -- | (100%) 3.49M to 15.63K | |
15-Dec-21 2:56 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 13-Dec-21 | Disposition (other) | 2,174,180 | -- | -- | (96%) 2.27M to 95.24K | |
06-Dec-21 7:28 PM View: | Effector Therapeutics, Inc. (EFTR) | 02-Dec-21 | Market Sale Duplicate | 8,113 | $5.68 | $46,081.80 | (< 1%) 4.53M to 4.52M | (< 1%) |
01-Dec-21 6:31 PM View: | Effector Therapeutics, Inc. (EFTR) | 01-Dec-21 | Market Sale | 19,245 | $6.44 | $123,880.00 | (< 1%) 4.55M to 4.53M | (2%) |
01-Dec-21 6:31 PM View: | Effector Therapeutics, Inc. (EFTR) | 30-Nov-21 | Market Sale | 27,409 | $6.53 | $179,036.00 | (< 1%) 4.58M to 4.55M | (< 1%) |
01-Dec-21 6:31 PM View: | Effector Therapeutics, Inc. (EFTR) | 29-Nov-21 | Market Sale | 25,764 | $6.70 | $172,490.00 | (< 1%) 4.61M to 4.58M | 2% |
26-Nov-21 4:44 PM View: | Effector Therapeutics, Inc. (EFTR) | 26-Nov-21 | Market Sale Duplicate | 5,026 | $7.01 | $35,241.70 | (< 1%) 4.61M to 4.61M | (5%) |
26-Nov-21 4:44 PM View: | Effector Therapeutics, Inc. (EFTR) | 24-Nov-21 | Market Sale Duplicate | 36,520 | $7.36 | $268,605.00 | (< 1%) 4.65M to 4.61M | < 1% |
26-Nov-21 4:44 PM View: | Effector Therapeutics, Inc. (EFTR) | 23-Nov-21 | Market Sale Duplicate | 14,879 | $7.40 | $110,150.00 | (< 1%) 4.66M to 4.65M | < 1% |
22-Nov-21 7:13 PM View: | Effector Therapeutics, Inc. (EFTR) | 22-Nov-21 | Market Sale Duplicate | 26,183 | $7.86 | $205,798.00 | (< 1%) 4.69M to 4.66M | (2%) |
22-Nov-21 7:13 PM View: | Effector Therapeutics, Inc. (EFTR) | 19-Nov-21 | Market Sale Duplicate | 7,241 | $8.12 | $58,803.90 | (< 1%) 4.69M to 4.69M | < 1% |
22-Nov-21 7:13 PM View: | Effector Therapeutics, Inc. (EFTR) | 18-Nov-21 | Market Sale Duplicate | 16,745 | $8.53 | $142,801.00 | (< 1%) 4.71M to 4.69M | 6% |
17-Nov-21 7:56 PM View: | Effector Therapeutics, Inc. (EFTR) | 17-Nov-21 | Market Sale Duplicate | 10,235 | $9.13 | $93,415.20 | (< 1%) 4.72M to 4.71M | (4%) |
17-Nov-21 7:56 PM View: | Effector Therapeutics, Inc. (EFTR) | 16-Nov-21 | Market Sale Duplicate | 8,319 | $9.42 | $78,356.90 | (< 1%) 4.73M to 4.72M | (1%) |
18-Mar-22 5:10 PM View: | Inari Medical, Inc. (NARI) | 15-Nov-21 | Market Purchase | 303 | $89.08 | $26,992.50 | < 1% 526.26K to 526.56K | |
18-Mar-22 5:14 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 15-Nov-21 | Market Purchase | 2,014 | $8.85 | $17,823.90 | < 1% 2.27M to 2.27M | (39%) |
17-Nov-21 7:56 PM View: | Effector Therapeutics, Inc. (EFTR) | 15-Nov-21 | Market Sale Duplicate | 5,071 | $9.81 | $49,751.30 | (< 1%) 4.74M to 4.73M | 3% |
12-Nov-21 5:53 PM View: | Effector Therapeutics, Inc. (EFTR) | 12-Nov-21 | Sale Duplicate | 12,000 | $10.07 | $120,840.00 | (< 1%) 4.75M to 4.74M | |
12-Nov-21 5:53 PM View: | Effector Therapeutics, Inc. (EFTR) | 11-Nov-21 | Sale Duplicate | 12,017 | $10.37 | $124,592.00 | (< 1%) 4.76M to 4.75M | |
12-Nov-21 5:53 PM View: | Effector Therapeutics, Inc. (EFTR) | 10-Nov-21 | Sale Duplicate | 34,000 | $10.44 | $354,824.00 | (< 1%) 4.79M to 4.76M | |
12-Nov-21 5:53 PM View: | Effector Therapeutics, Inc. (EFTR) | 09-Nov-21 | Sale Duplicate | 28,785 | $11.00 | $316,750.00 | (< 1%) 4.82M to 4.79M | |
27-Aug-21 6:50 PM View: | Effector Therapeutics, Inc. (EFTR) | 25-Aug-21 | Grant | 4,822,110 | $1.48 | $7,127,850.00 | 100% 0 to 4.82M | |
28-May-21 6:37 PM View: | Inari Medical, Inc. (NARI) | 27-May-21 | Grant | 1,380 | -- | -- | < 1% 521.86K to 523.24K | |
28-May-21 6:37 PM View: | Inari Medical, Inc. (NARI) | 27-May-21 | Option Exercise | 2,982 | -- | -- | < 1% 523.24K to 526.23K | |
17-May-21 6:44 PM View: | Inari Medical, Inc. (NARI) | 13-May-21 | Acquisition (other) | 685,826 | -- | -- | 18% 3.82M to 4.5M | |
17-May-21 6:44 PM View: | Inari Medical, Inc. (NARI) | 13-May-21 | Acquisition (other) | 93,972 | -- | -- | 2% 4.5M to 4.6M | |
17-May-21 6:44 PM View: | Inari Medical, Inc. (NARI) | 13-May-21 | Disposition (other) | 3,389,510 | -- | -- | (74%) 4.6M to 1.21M | |
31-Mar-21 7:12 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 30-Mar-21 | Conversion | 3,473,540 | -- | -- | 100% 0 to 3.47M | |
31-Mar-21 7:12 PM View: | Edgewise Therapeutics, Inc. (EWTX) | 30-Mar-21 | Purchase | 15,625 | $16.00 | $250,000.00 | < 1% 3.47M to 3.49M | |
18-Mar-21 6:38 PM View: | Inari Medical, Inc. (NARI) | 16-Mar-21 | Acquisition (other) | 685,827 | -- | -- | 11% 6.43M to 7.11M | |
18-Mar-21 6:38 PM View: | Inari Medical, Inc. (NARI) | 16-Mar-21 | Acquisition (other) | 94,101 | -- | -- | 1% 7.11M to 7.21M | |
18-Mar-21 6:38 PM View: | Inari Medical, Inc. (NARI) | 16-Mar-21 | Disposition (other) Duplicate | 3,389,510 | -- | -- | (47%) 7.21M to 3.82M | |
18-Mar-22 5:14 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 03-Mar-21 | Market Purchase | 350 | $52.07 | $18,224.50 | < 1% 2.27M to 2.27M | (90%) |
08-Dec-20 8:46 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 08-Dec-20 | Conversion | 2,174,180 | -- | -- | 100% 0 to 2.17M | |
08-Dec-20 8:46 PM View: | Ars Pharmaceuticals, Inc. (SPRY) | 08-Dec-20 | Purchase | 95,238 | $21.00 | $2,000,000.00 | 4% 2.17M to 2.27M | |
19-Nov-20 9:01 PM View: | Inari Medical, Inc. (NARI) | 17-Nov-20 | Acquisition (other) | 587,851 | -- | -- | 7% 8.31M to 8.9M | |
19-Nov-20 9:01 PM View: | Inari Medical, Inc. (NARI) | 17-Nov-20 | Acquisition (other) | 81,996 | -- | -- | < 1% 8.9M to 8.98M | |
19-Nov-20 9:01 PM View: | Inari Medical, Inc. (NARI) | 17-Nov-20 | Disposition (other) | 2,905,300 | -- | -- | (32%) 8.98M to 6.08M | |
18-Mar-22 5:10 PM View: | Inari Medical, Inc. (NARI) | 22-Jun-20 | Purchase | 32 | $46.61 | $1,491.65 | < 1% 526.23K to 526.26K | |
27-May-20 6:38 PM View: | Inari Medical, Inc. (NARI) | 27-May-20 | Conversion | 7,724,820 | -- | -- | 100% 0 to 7.72M | |
27-May-20 6:38 PM View: | Inari Medical, Inc. (NARI) | 27-May-20 | Purchase | 251,795 | $19.00 | $4,784,100.00 | 3% 7.72M to 7.98M | |
23-Apr-19 4:16 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 23-Apr-19 | Disposition (change in control) | 121,020 | -- | -- | (100%) 121.02K to 0 | |
26-May-17 11:57 AM View: | Oncomed Pharmaceuticals Inc (OMED) | 26-May-17 | Market Sale | 9,580 | $3.70 | $35,463.20 | (7%) 130.6K to 121.02K | 75% |
26-May-17 11:57 AM View: | Oncomed Pharmaceuticals Inc (OMED) | 24-May-17 | Market Sale | 4,300 | $3.72 | $15,977.90 | (3%) 134.9K to 130.6K | 75% |
22-May-17 8:16 PM View: | Oncomed Pharmaceuticals Inc (OMED) | 19-May-17 | Market Sale | 7,487 | $3.70 | $27,711.60 | (5%) 142.39K to 134.9K | 75% |